Showing results (51-60 of 326) with videos related to
Sort By:
Pageof 33
The Journal of Clinical Investigation|November 1, 1994
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragmentsM Basta, M C DalakasActa Neuropathologica|January 1, 1986
Characterization of amyloid deposits in biopsies of 15 with "sporadic" (non-familial or plasma cell dyscrasia amyloid polyneuropathyM C Dalakas, G CunninghamAnnals of Neurology|April 20, 2001
Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutationsM Li, M C DalakasBrain : a Journal of Neurology|July 25, 2000
Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathyK Murata, M C DalakasProceedings of the National Academy of Sciences of the United States of America|October 24, 1995
Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenazi Jewish patients with Tarui diseaseO Vasconcelos, K Sivakumar, M C Dalakas, et al.Neurology|May 1, 1993
Treatment of inclusion-body myositis with high-dose intravenous immunoglobulinS A Soueidan, M C DalakasThe New England Journal of Medicine|April 25, 1991
Dysphagia in patients with the post-polio syndromeB C Sonies, M C DalakasClinical and Experimental Immunology|December 30, 2014
7th International Immunoglobulin Conference: Interlaken Leadership AwardsM C Dalakas, W N LöscherNeurology|January 15, 2000
Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathiesY C Choi, M C DalakasPageof 33